Home/Browse by collection/Cancer Immunotherapy in Understudied Populations

Cancer Immunotherapy in Understudied Populations

Edited by Kavita Dhodapkar and Johanneke E. A. Portielje Significant gaps and disparities persist with respect to cancer immunotherapy research across populations and a range of factors, including age, race, and social determinants of health, at the clinical and biological levels. Furthermore, the impact of these factors and the response to existing therapies are neither uniform nor clearly understood. This series covers various aspects of understudied demographics and addresses immunotherapy treatments, both for solid cancers and hemato-oncology, and immune response among these groups. Authored by leading voices from diverse backgrounds, “Cancer Immunotherapy in Understudied Populations” highlights issues that impact aging- and DEI-related research in the current immuno-oncology landscape and aims to inspire researchers who will fill knowledge gaps in immunotherapy with respect to the roles of aging, race, ethnicity and social determinants of health. Check the collection throughout 2024 for new publications.

Showing results 1 - 4 of 4

Sorted by most recent